Question 70

CellCept is used in REMS to prevent pregnancy.

CellCept, known generically as mycophenolate mofetil, is part of a Risk Evaluation and Mitigation Strategy (REMS) due to its potential teratogenic effects, making it crucial to prevent pregnancy during its use.

A) Creon

Creon is a pancreatic enzyme replacement therapy used for patients with pancreatic insufficiency. It does not have implications regarding pregnancy prevention and is not part of any REMS program.

B) CellCept

CellCept is specifically included in a REMS program because it poses significant risks of birth defects and miscarriage. Therefore, it is essential for healthcare providers to ensure that female patients are not pregnant before starting the medication and to use effective contraception during treatment.

C) Celexa

Celexa, or citalopram, is an antidepressant that does not carry significant risks for pregnancy and is not included in a REMS program. While it may have some considerations regarding use in pregnant individuals, it is not specifically aimed at preventing pregnancy.

D) Cialis

Cialis, or tadalafil, is a medication used to treat erectile dysfunction and does not have any REMS associated with pregnancy prevention. It does not pose the same teratogenic risks as CellCept and is not indicated for use in pregnancy-related scenarios.

Conclusion

CellCept is the only option listed that is associated with a REMS program aimed at preventing pregnancy due to its high risk of causing serious birth defects. All other options fail to meet this criterion, either because they are unrelated to pregnancy prevention or do not have significant teratogenic risks. Thus, CellCept is the definitive answer regarding REMS to prevent pregnancy.